These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 37448436)

  • 1. Public Knowledge About COVID-19 Booster Vaccines in Pakistan: A Study Conducted in a Tertiary Care Hospital in Karachi.
    Khan M; Jabeen S; Khizer Ali S; Tofique MH; Shabbir MS; Baig R; Khalili MN; Kumar S; Khatri M; Varrassi G; Sapna F; Dass A; Kumar N
    Cureus; 2023 Jun; 15(6):e40284. PubMed ID: 37448436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
    Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications.
    Mustafa ZU; Maqbool F; Wahid M; Salman M; Haroon S; Khan YH; Mallhi TH; Godman B
    Rev Soc Bras Med Trop; 2023; 56():e0044. PubMed ID: 37283345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study.
    Dziedzic A; Issa J; Hussain S; Tanasiewicz M; Wojtyczka R; Kubina R; Konwinska MD; Riad A
    Front Public Health; 2022; 10():938067. PubMed ID: 35958845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru.
    Bendezu-Quispe G; Caira-Chuquineyra B; Fernandez-Guzman D; Urrunaga-Pastor D; Herrera-Añazco P; Benites-Zapata VA
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance of Booster COVID-19 Vaccine and Its Association with Components of Vaccination Readiness in the General Population: A Cross-Sectional Survey for Starting Booster Dose in Japan.
    Tokiya M; Hara M; Matsumoto A; Ashenagar MS; Nakano T; Hirota Y
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece.
    Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the reasons for refusing a COVID-19 vaccine? A qualitative analysis of social media in Germany.
    Fieselmann J; Annac K; Erdsiek F; Yilmaz-Aslan Y; Brzoska P
    BMC Public Health; 2022 Apr; 22(1):846. PubMed ID: 35484619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK.
    Paul E; Fancourt D
    Lancet Reg Health Eur; 2022 Mar; 14():100317. PubMed ID: 35132400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England.
    Andrews N; Stowe J; Kirsebom F; Toffa S; Sachdeva R; Gower C; Ramsay M; Lopez Bernal J
    Nat Med; 2022 Apr; 28(4):831-837. PubMed ID: 35045566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19: Early studies give hope omicron is milder than other variants.
    Christie B
    BMJ; 2021 Dec; 375():n3144. PubMed ID: 34949600
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.